Neurologists Describe Childhood Absence Epilepsy as 'Underrecognized' but 'Easily Diagnosed and Treated'
Expanding awareness of Childhood Absence Epilepsy helps early diagnosis and treatment
WASHINGTON, May 6, 2024 /PRNewswire/ -- The subtlety of childhood absence epilepsy (CAE) seizures, coupled with their close association with learning and mental health difficulties, can delay diagnosis despite CAE being one of the most common pediatric syndromes in the United States, according to a new expert-led clinical proceedings paper from the Clinical Neurological Society of America.
Childhood absence epilepsy seizures are brief staring spells with loss of awareness that cannot be interrupted by voice or touch. Seizures can occur multiple times per day. CAE may go undiagnosed or misdiagnosed because it can be mistaken for ADHD or be difficult for parents, teachers and other caregivers to recognize. While CAE usually remits within two years of onset or by early adolescence, the impact on children's social and emotional health can be long term.
Improving awareness of the disease among parents, teachers, health care providers and the community at large;
Increasing understanding of its link to ADHD and other learning and mental health challenges; and
Improving access to diagnosis and treatment.
Expert Panelists:
Katy Lalor, MD (Clinical Proceedings Chair)
Allison Conravey, MD
Sudha Kilaru Kessler, MD
Elaine C. Wirrell, MD
Statement from Katy Lalor, MD, Clinical Proceedings Chair:
"Expanding awareness among the public of CAE is the first step to earlier diagnosis and treatment. And with a greater understanding of CAE's link to ADHD and other learning and mental health challenges, we can reduce the burden of this disease and improve the short-term and long-term outcomes of these children."
The Clinical Neurological Society of America, a non-profit 501(c)(6), is a nationwide organization of neurology clinicians with a mission to improve clinical practice and patient care through education.
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...
Product: Kalihim (Philippine Bread Roll)
Issue: Food - Allergen - Egg
Distribution: British Columbia
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...